← Back to Search

MAC Therapy for Anxiety in Cancer Patients

N/A
Waitlist Available
Led By Kelly Trevino, PhD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Confirmed diagnosis of breast, lymphoma, genitourinary, thoracic, gynecological or gastrointestinal cancer, currently on active treatment or within six months of completion of treatment
As determined by the patient's primary oncologist and/or study staff, physically and cognitively able to complete study procedures
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (1-2 weeks after enrollment) and follow-up (7-9 weeks after baseline)
Awards & highlights

Study Summary

This trial is testing a new therapy to help manage anxiety in cancer patients and their caregivers. The therapy is different from usual care because it uses a plan that has been shown to work in previous studies. This study includes people 65 years of age and older.

Who is the study for?
This trial is for older adults (65+) with certain types of cancer and their caregivers, who live in New York or can attend sessions there. Participants must speak English well, be able to consent, and use the phone for sessions. At least one member of each patient-caregiver pair should have noticeable anxiety. Exclusions include suicidal thoughts, severe weakness or cognitive impairment, recent cognitive-behavioral therapy, schizophrenia, substance issues, bipolar disorder or pregnancy in caregivers.Check my eligibility
What is being tested?
The MAC intervention is being tested against usual care to see if it better manages anxiety in older adults with cancer and their caregivers. MAC includes a proven plan tailored for those aged 65+ and involves primary caregivers to enhance support.See study design
What are the potential side effects?
Since this trial tests a psychological therapy rather than medication, traditional side effects are not expected. However participants may experience emotional discomfort discussing personal topics during therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a specific type of cancer and am currently undergoing treatment or have completed treatment within the last six months.
Select...
My doctor agrees I can physically and mentally participate in the study.
Select...
I am 65 years old or older.
Select...
I am capable of understanding and giving informed consent.
Select...
I speak English very well.
Select...
I can talk on the phone for appointments.
Select...
I am a patient seeking treatment.
Select...
I am 65 years old or older.
Select...
I am 21 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (1-2 weeks after enrollment) and follow-up (7-9 weeks after baseline)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (1-2 weeks after enrollment) and follow-up (7-9 weeks after baseline) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anxiety sub-scale of the Hospital Anxiety and Depression Scale
Hamilton Anxiety Rating Scale
Secondary outcome measures
Caregiver Quality of Life-Cancer (caregivers only)
Depression sub-scale of the Hospital Anxiety and Depression Scale
Distress Thermometer
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Managing Anxiety from Cancer (MAC)Experimental Treatment1 Intervention
Older adults with cancer and their primary informal caregiver will receive a seven-session cognitive-behavior therapy intervention administered over the telephone by a trained study interventionist. The intervention is administered weekly and each session is 45-50 minutes in length. Patients and caregivers will receive the intervention independently and from separate therapists.
Group II: Usual CareActive Control1 Intervention
Older adults with cancer and their primary informal caregiver will receive standard care provided by their medical team. These participants will not receive any intervention from the research team.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Managing Anxiety from Cancer (MAC)
2016
N/A
~50

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,928 Previous Clinical Trials
591,782 Total Patients Enrolled
1 Trials studying Anxiety
50 Patients Enrolled for Anxiety
Weill Medical College of Cornell UniversityOTHER
1,052 Previous Clinical Trials
1,329,846 Total Patients Enrolled
8 Trials studying Anxiety
351 Patients Enrolled for Anxiety
National Institute on Aging (NIA)NIH
1,655 Previous Clinical Trials
28,004,144 Total Patients Enrolled
12 Trials studying Anxiety
2,761 Patients Enrolled for Anxiety

Media Library

Managing Anxiety from Cancer (MAC) Clinical Trial Eligibility Overview. Trial Name: NCT03168971 — N/A
Anxiety Research Study Groups: Managing Anxiety from Cancer (MAC), Usual Care
Anxiety Clinical Trial 2023: Managing Anxiety from Cancer (MAC) Highlights & Side Effects. Trial Name: NCT03168971 — N/A
Managing Anxiety from Cancer (MAC) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03168971 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers still accepting participants in this trial?

"This research trial, which was originally posted on January 23 2019 and last updated December 6 2021, is no longer actively seeking patients. However, there are still 1747 other medical studies that need volunteers to participate at this time."

Answered by AI

What does this research endeavor seek to accomplish?

"This study seeks to evaluate patient moods through the baseline and follow-up periods with their scores on Hamilton Anxiety Rating Scale serving as its primary objective. Secondary objectives involve assessing shifts in distress levels, emotional quality of life, and depression via Distress Thermometer, Functional Assessment of Cancer Therapy-General: Emotional Quality of Life Sub-Scale (patients only), and Depression sub-scale of the Hospital Anxiety and Depression Scale respectively."

Answered by AI
~3 spots leftby Jan 2025